VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Are referred to the Cachexia Clinic with           │ Are referred to the Cachexia Clinic with           │     100 │
│ involuntary weight loss of \>5% of their premorbid │ involuntary weight loss of >5% of their premorbid  │         │
│ weight within the previous 6 months                │ weight within the previous 6 months                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Are 18 years of age or older                       │ Are 18 years of age or older                       │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Have a Karnofsky performance score of 60 or higher │ Have a Karnofsky performance score of 60 or higher │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Can maintain oral food intake during the study     │ Can maintain oral food intake during the study     │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Can understand the study procedures and can sign   │ Can understand the study procedures and can sign   │     100 │
│ an informed consent form                           │ an informed consent form                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Are not currently taking melatonin                 │ Are not currently taking melatonin                 │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Are taking megestrol acetate and continue to lose  │ Are taking megestrol acetate and continue to lose  │     100 │
│ weight despite at least 2 weeks of therapy         │ weight despite at least 2 weeks of therapy         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Have dementia or delirium (as determined by the    │ Have dementia or delirium (as determined by the    │     100 │
│ palliative care specialist) at study entry         │ palliative care specialist) at study entry         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Are pregnant                                       │ Are pregnant                                       │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Have been taking corticosteroids for longer than   │ Have been taking corticosteroids for longer than   │     100 │
│ 48 hours                                           │ 48 hours                                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Have pulmonary edema, ascites or pitting edema on  │ Have pulmonary edema, ascites or pitting edema on  │     100 │
│ clinical examination                               │ clinical examination                               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Are unable to walk                                 │ Are unable to walk                                 │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Have a history of serious adverse gastrointestinal │ Have a history of serious adverse gastrointestinal │     100 │
│ events (i.e., bleeding or perforation),history of  │ events (i.e., bleeding or perforation),history of  │         │
│ a coagulopathy or current anti-coagulant use       │ a coagulopathy or current anti-coagulant use       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients on methotrexate                           │ Patients on methotrexate                           │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Have a calculated creatinine clearance of \>/= 60  │ Have a calculated creatinine clearance of >/= 60   │      99 │
│ cc/min                                             │ cc/min                                             │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Have an ALT/AST\>3x upper limit of normal          │ Have an ALT/AST>3x upper limit of normal           │      99 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients taking melatonin receptor agonists (such  │ Patients taking melatonin receptor agonists (such  │      99 │
│ as Rozerem® \[ramelteon\])                         │ as Rozerem® [ramelteon])                           │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤══════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                │   Score │
╞═══════════════════════════════════╪══════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years │ Are 18 years of age or older │      39 │
╘═══════════════════════════════════╧══════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 98
Average Levenshtein Ratio of individual lines: 96.44444444444444
OverAll Ratio: 97.22222222222223
